CLRB vs NKE · $20.8M cap vs P/E 35, rev $46.40B
Cellectar Biosciences Inc (CLRB) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Cellectar Biosciences Inc (CLRB) is a biotechnology company listed on US.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by Elliott J. Hill.
CLRB does not have a complete income-statement cache yet.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. Revenue was up 0.2% from 2025-05-31 to 2026-05-31. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
CLRB currently screens at market cap $20.8M. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the CLRB and NKE stock pages for the full models.
Not investment advice.